Prothena Corporation PLC
NASDAQ:PRTA

Watchlist Manager
Prothena Corporation PLC Logo
Prothena Corporation PLC
NASDAQ:PRTA
Watchlist
Price: 10.73 USD -3.07% Market Closed
Market Cap: 577.6m USD

Relative Value

The Relative Value of one PRTA stock under the Base Case scenario is hidden USD. Compared to the current market price of 10.73 USD, Prothena Corporation PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRTA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
33
vs Industry
60
Median 3Y
18.3
Median 5Y
18.3
Industry
7.9
Forward
51.2
vs History
vs Industry
Median 3Y
-10
Median 5Y
-7.7
Industry
24
Forward
-2.2
vs History
vs Industry
Median 3Y
-11
Median 5Y
-6
Industry
21.6
vs History
vs Industry
Median 3Y
-10.8
Median 5Y
-6
Industry
23.7
vs History
74
vs Industry
51
Median 3Y
2.2
Median 5Y
3.2
Industry
3.4
vs History
38
vs Industry
70
Median 3Y
9.3
Median 5Y
10
Industry
8.3
Forward
21.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.3
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-4
Industry
6.7
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-4
Industry
7.2
Forward
-1.1
vs History
vs Industry
Median 3Y
-5.5
Median 5Y
-2.5
Industry
8.2
vs History
vs Industry
Median 3Y
-5.3
Median 5Y
-2.5
Industry
6.7
vs History
53
vs Industry
37
Median 3Y
17.5
Median 5Y
23.5
Industry
5.7

Multiples Across Competitors

PRTA Competitors Multiples
Prothena Corporation PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IE
Prothena Corporation PLC
NASDAQ:PRTA
577.6m USD 49 -2.1 -1.1 -1.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 067 817 -161 919.3 -196 621.7 -194 378
US
Abbvie Inc
NYSE:ABBV
394.3B USD 6.6 167.9 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
172.8B USD 4.8 24.7 17.9 17.9
US
Gilead Sciences Inc
NASDAQ:GILD
150.5B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD 9.6 30.6 22.4 23.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.9 -527.7 -574.6 -559.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.1B USD 5.2 16.2 15.3 17.4
AU
CSL Ltd
ASX:CSL
88.6B AUD 3.8 19.5 13.1 16.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
56.7B USD 17.7 1 300.9 171.3 207.7
NL
argenx SE
XBRU:ARGX
47.9B EUR 15.5 36.4 63.1 64.9
P/E Multiple
Earnings Growth PEG
IE
Prothena Corporation PLC
NASDAQ:PRTA
Average P/E: 201.8
Negative Multiple: -2.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 919.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
167.9
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.7
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.6
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
9%
1.8
AU
CSL Ltd
ASX:CSL
19.5
11%
1.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 300.9
N/A N/A
NL
argenx SE
XBRU:ARGX
36.4
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IE
Prothena Corporation PLC
NASDAQ:PRTA
Average EV/EBITDA: 41.5
Negative Multiple: -1.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 621.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.9
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.4
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.3
11%
1.4
AU
CSL Ltd
ASX:CSL
13.1
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
171.3
N/A N/A
NL
argenx SE
XBRU:ARGX
63.1
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IE
Prothena Corporation PLC
NASDAQ:PRTA
Average EV/EBIT: 47.9
Negative Multiple: -1.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 378 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.9
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.4
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.4
13%
1.3
AU
CSL Ltd
ASX:CSL
16.4
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
207.7
N/A N/A
NL
argenx SE
XBRU:ARGX
64.9
N/A N/A